Houston-first directory · 6 checked local clinicians · No patient lead forms
pPEPTIDE HEALTHDIRECTORY & EVIDENCE NOTES
← FDA shortage tracker

Liraglutide

Regulatory registry

Context
FDA-approved product context
Reason / limits
Product-specific diabetes information. Do not merge every liraglutide brand or indication.
Last source review
October 10, 2026
Review scope
Earlier editorial source context. Not a new medical or regulatory review.
Clinical phase
Unknown: no current trial-specific phase check is included in this registry.
Registry NDC / manufacturer
Unknown unless linked to a matched FDA package record below.

Research-only means this library makes no approved-treatment claim. Compounding context does not mean compounded-only, authorized for compounding, or legally available. Product-specific source limits control.

Regulatory sources

Original regulatory / editorial source

Read the full evidence note

FDA shortage tracker

Approval context and shortage status are separate. An NDC identifies a package; it does not establish FDA approval or permission to compound.

FDA current shortage record

FDA lists a current shortage for at least one matched product/package. Other presentations may differ; this is not a pharmacy inventory check.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Full dated shortage record · All compound tracker entries

Matched package records (11)

Records match a single exact active substance. Route and presentation are shown separately; a record does not apply to every product or preparation.

Liraglutide Injection

Package NDC
0480-3667-20
Manufacturer
Novo Nordisk, Inc.
Product / route
LIRAGLUTIDE / SUBCUTANEOUS
FDA record status
Current
Reported availability
Available
FDA reason
Not supplied
FDA record updated
09/22/2026

FDA API record for this package

Liraglutide Injection

Package NDC
0169-4060-13
Manufacturer
Novo Nordisk, Inc.
Product / route
VICTOZA / SUBCUTANEOUS
FDA record status
Current
Reported availability
Limited Availability
FDA reason
Delay in shipping of the drug
FDA record updated
09/22/2026

FDA API record for this package

Liraglutide Injection

Package NDC
0143-9144-03
Manufacturer
Hikma Pharmaceuticals USA, Inc.
Product / route
LIRAGLUTIDE / SUBCUTANEOUS
FDA record status
Current
Reported availability
Available
FDA reason
Not supplied
FDA record updated
10/14/2026

FDA API record for this package

Liraglutide Injection

Package NDC
0169-2800-15
Manufacturer
Novo Nordisk, Inc.
Product / route
SAXENDA / SUBCUTANEOUS
FDA record status
To Be Discontinued
Reported availability
Unknown
FDA reason
Not supplied
FDA record updated
08/25/2026

FDA API record for this package

Liraglutide Injection

Package NDC
71288-563-84
Manufacturer
Meitheal Pharmaceuticals, Inc.
Product / route
LIRAGLUTIDE / SUBCUTANEOUS
FDA record status
Current
Reported availability
Available
FDA reason
Not supplied
FDA record updated
08/27/2026

FDA API record for this package

Liraglutide Injection

Package NDC
0480-7250-46
Manufacturer
Teva Pharmaceuticals USA, Inc.
Product / route
LIRAGLUTIDE / SUBCUTANEOUS
FDA record status
To Be Discontinued
Reported availability
Unknown
FDA reason
Not supplied
FDA record updated
05/14/2026

FDA API record for this package

Liraglutide Injection

Package NDC
71288-563-85
Manufacturer
Meitheal Pharmaceuticals, Inc.
Product / route
LIRAGLUTIDE / SUBCUTANEOUS
FDA record status
Current
Reported availability
Available
FDA reason
Not supplied
FDA record updated
08/27/2026

FDA API record for this package

Liraglutide Injection

Package NDC
0169-2800-15
Manufacturer
Novo Nordisk, Inc.
Product / route
SAXENDA / SUBCUTANEOUS
FDA record status
Current
Reported availability
Limited Availability
FDA reason
Discontinuation of the manufacture of the drug
FDA record updated
09/22/2026

FDA API record for this package

Related FDA information

Liraglutide Injection

Package NDC
0143-9144-02
Manufacturer
Hikma Pharmaceuticals USA, Inc.
Product / route
LIRAGLUTIDE / SUBCUTANEOUS
FDA record status
Current
Reported availability
Available
FDA reason
Not supplied
FDA record updated
10/14/2026

FDA API record for this package

Liraglutide Injection

Package NDC
0169-4060-12
Manufacturer
Novo Nordisk, Inc.
Product / route
VICTOZA / SUBCUTANEOUS
FDA record status
Current
Reported availability
Limited Availability
FDA reason
Delay in shipping of the drug
FDA record updated
09/22/2026

FDA API record for this package

Liraglutide Injection

Package NDC
0480-3667-22
Manufacturer
Novo Nordisk, Inc.
Product / route
LIRAGLUTIDE / SUBCUTANEOUS
FDA record status
Current
Reported availability
Available
FDA reason
Not supplied
FDA record updated
09/22/2026

FDA API record for this package

Observed change history (1)

Observed dates are when our sync saw a source state, not when a shortage started or ended. Unchanged daily checks do not add duplicate events.